"The Heart Hospital of New Mexico at Lovelace Medical Center is the only hospital in New Mexico that is entirely dedicated to heart care. Our skilled team use state-of-the-art technology, offering treatment options for all types of heart and vascular conditions"

During the past decade, New Mexico Heart Institute conducted 27 clinical trials. In the 10-year time frame, 27 clinical trials started and 15 clinical trials were completed, i.e. on average, 55.6% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 10 clinical trials were completed. i.e. 166.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "New Mexico Heart Institute" #1 sponsor was "Abbott Medical Devices" with 11 trials, followed by "Boston Scientific Corporation" with 7 trials sponsored, "Medtronic Cardiac Rhythm and Heart Failure" with 3 trials sponsored, "AtriCure, Inc." with 2 trials sponsored and "Endologix" with 2 trials sponsored. Other sponsors include 18 different institutions and companies that sponsored additional 25 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "New Mexico Heart Institute" #1 collaborator was "Massachusetts General Hospital" with 2 trials as a collaborator, "Abbott" with 1 trials as a collaborator, "Acelis Connected Health" with 1 trials as a collaborator, "Avania" with 1 trials as a collaborator and "Bard Ltd" with 1 trials as a collaborator. Other collaborators include 24 different institutions and companies that were collaborators in the rest 34 trials.

According to Clinical.Site data, the most researched conditions in "New Mexico Heart Institute" are "Atrial Fibrillation" (9 trials), "Heart Failure" (5 trials), "Coronary Artery Disease" (4 trials), "Critical Limb Ischemia" (4 trials) and "Peripheral Arterial Disease" (4 trials). Many other conditions were trialed in "New Mexico Heart Institute" in a lesser frequency.

Most popular intervention types in "New Mexico Heart Institute" are "Device" (38 trials), "Drug" (9 trials), "Procedure" (4 trials), "Diagnostic Test" (2 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "LARIAT + PVI" (2 trials), "Surgical RF Ablation" (2 trials), "Tack Endovascular System" (2 trials), "Adagio AF Cryoablation System (iCLAS™)" (1 trials) and "Any Abiomed Impella® device approved for use in high-risk PCI" (1 trials). Other intervention names were less common.

The vast majority of trials in "New Mexico Heart Institute" are 48 trials for "All" genders.

Currently, there are NaN active trials in "New Mexico Heart Institute". undefined are not yet recruiting, 4 are recruiting, 10 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 25 completed trials in New Mexico Heart Institute, 1 suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in New Mexico Heart Institute, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 23 trials that are defined as “Not Applicable".